OSM and anemia: In this issue of the JCI, Garrigue, Kermasson, and colleagues demonstrate that human oncostatin M (OSM) deficiency underlies profound anemia, thrombocytopenia, and neutropenia, unraveling another inherited bone marrow failure syndrome (IBMFS) (1).